Fifth Third Bancorp’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-370
Closed -$4K 2790
2021
Q2
$4K Buy
+370
New +$3.48K ﹤0.01% 2270

Other funds holding TRIL

Fifth Third Bancorp's TRIL Position: Q3 2021 in Review

Fifth Third Bancorp sold out of Trillium Therapeutics Inc. (TRIL) in Q3 2021, closing a stake of 370 shares — an estimated $4K sold.

Fifth Third Bancorp first reported a position in TRIL in Q2 2021 and held it in 1 quarter. The position peaked at $4K in Q2 2021. 181 funds tracked by Wall St. Rank hold TRIL as of Q3 2021.

  • Fifth Third Bancorp reported no remaining Trillium Therapeutics Inc. position as of Q3 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 370 Trillium Therapeutics Inc. shares in Q3 2021, an estimated $4K.
  • Fifth Third Bancorp first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 1 quarter.
  • Fifth Third Bancorp's Trillium Therapeutics Inc. position peaked at $4K in Q2 2021.
  • 181 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q3 2021.

Based on Fifth Third Bancorp's 13F filing for Q3 2021, filed 15 Oct 2021.